SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-000648
Filing Date
2018-01-29
Accepted
2018-01-29 10:14:51
Documents
5
Period of Report
2018-01-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K menlo8-k.htm 8-K 33056
2 EXHIBIT 3.1 exhibit31.htm EX-3.1 34109
3 EXHIBIT 3.2 exhibit32.htm EX-3.2 185041
4 EXHIBIT 99.1 exhibit991.htm EX-99.1 6667
5 EXHIBIT 99.2 exhibit992.htm EX-99.2 6330
  Complete submission text file 0001628280-18-000648.txt   266477
Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 18553789
SIC: 2834 Pharmaceutical Preparations